Efficiency and safety of linezol in the treatment of neonatal sepsis

LIU Wei; CHEN Ling; ZHUAN Chen-Yu

doi:10.7499/j.issn.1008-8830.2015.04.023

PDF(1217 KB)

Chinese Journal of Contemporary Pediatrics ›› 2015, Vol. 17 ›› Issue (4) : 405-407. DOI: 10.7499/j.issn.1008-8830.2015.04.023

CLINICAL EXPERIENCE

Efficiency and safety of linezol in the treatment of neonatal sepsis

LIU Wei, CHEN Ling, ZHUAN Chen-Yu

Author information +

History +

Abstract

No abstract available

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LIU Wei, CHEN Ling, ZHUAN Chen-Yu. Efficiency and safety of linezol in the treatment of neonatal sepsis[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(4): 405-407 https://doi.org/10.7499/j.issn.1008-8830.2015.04.023

References

[1] 邵肖梅, 叶鸿瑁, 丘小汕, 等. 实用新生儿学[M]. 北京: 人民卫生出版社, 2012: 340-347.
[2] Kocher S, Muller W, Resch B. Linezolid treatment of nosocomial bacterial infection with multiresistant Gram-positive pathogens in preterm infants: a systematic review[J]. Int J Antimicrob Agents, 2010, 36(2): 106-110.
[3] Welsh KJ, Abbott AN, Lewis EM. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin[J]. J Clin Microbiol, 2010, 48(3) : 894-899.
[4] 崔向丽, 赵志刚. 新型噁唑烷酮类抗生素利奈唑胺[J]. 中国新药杂志, 2008, 17(6): 530-532.
[5] Garazzino S, Tovo PA. Clinical experience with linezolid in infants and children [J]. J Antinicrob Chemother, 2011, 66 (S4): 23-41.
[6] 中华医学会儿科学分会新生儿学组, 中华医学会中华儿科杂志编辑委员会. 新生儿败血症诊疗方案[J]. 中华儿科杂志, 2003, 41(12): 897-899.
[7] 卫生部抗生素临床药理基地. 抗菌药物临床研究指导原则[J]. 中国临床药理学杂志, 1987, 3(2): 126-130.
[8] Deville JG, Adler S, Azimi PH, et al. Linezolid versus vancomycin in the treatment of known or suspected resistant Grampositive infections in neonates[J]. Pediatr Infect Dis J, 2003, 22(9): S158-S163.
[9] 王晓蕾, 孙海滨, 陈桃英, 等. 利奈唑胺治疗新生儿耐药革兰氏阳性球菌败血症临床分析[J]. 中国儿童保健杂志, 2013, 21(2): 213-214.
[10] Boselli EP. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator associated pneumonia[J]. Crit Care Med, 2005, 33(7) : 1529- 1534.
[11] Dryden MS. Linezolid pharmacokinetics and pharmacodynamics in clinical treatment[J]. J Antimicrob Chemother, 2011, 66 (Suppl 4): iv7-iv15.
[12] Langgartner M, Mutenthaler A, Haiden N, et al. Linezolid for treatment of catheter-related cerebrospinal fluid infections in preterm infants[J]. BMJ Case Rep, 2009, 11(5): 1217.
[13] Falagas ME, Siempos II, Vardakas KZ. Linezolid versus glycopeptides or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomized controlled trials [J]. Lancet Infect Dis, 2008, 8 (1) : 53-66.